Literature DB >> 11895366

Presenilin-1 protects against neuronal apoptosis caused by its interacting protein PAG.

Yan Zhou1, Wanjiang Zhang, Rachael Easton, James W Ray, Patricia Lampe, Zhihong Jiang, Anne L Brunkan, Alison Goate, Eugene M Johnson, Jane Y Wu.   

Abstract

Mutations in the presenilin-1 (PS-1) gene account for a significant fraction of familial Alzheimer's disease. The biological function of PS-1 is not well understood. We report here that the proliferation-associated gene (PAG) product, a protein of the thioredoxin peroxidase family, interacts with PS-1. Microinjection of a plasmid expressing PAG into superior cervical ganglion (SCG) sympathetic neurons in primary cultures led to apoptosis. Microinjection of plasmids expressing wild-type PS-1 or a PS-1 mutant with a deletion of exon 10 (PS1dE10) by themselves had no effect on the survival of primary SCG neurons. However, co-injection of wild-type PS-1 with PAG prevented neuronal death, whereas co-injection with the mutant PS-1 did not affect PAG-induced apoptosis. Furthermore, overexpression of PAG accelerated SCG neuronal death induced by nerve growth factor deprivation. This sensitizing effect was also blocked by wild-type PS-1, but not by PS1dE10. These results establish an assay for studying the function of PS-1 in primary neurons, reveal the neurotoxicity of a thioredoxin peroxidase, demonstrate a neuroprotective activity of the wild-type PS-1, and suggest possible involvement of defective neuroprotection by PS-1 mutants in neurodegeneration. (c)2002 Elsevier Science (USA).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11895366     DOI: 10.1006/nbdi.2001.0472

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  8 in total

1.  Antioxidant proteins TSA and PAG interact synergistically with Presenilin to modulate Notch signaling in Drosophila.

Authors:  Michael F Wangler; Lawrence T Reiter; Georgianna Zimm; Jennifer Trimble-Morgan; Jane Wu; Ethan Bier
Journal:  Protein Cell       Date:  2011-08-06       Impact factor: 14.870

2.  An ALS-associated mutation affecting TDP-43 enhances protein aggregation, fibril formation and neurotoxicity.

Authors:  Weirui Guo; Yanbo Chen; Xiaohong Zhou; Amar Kar; Payal Ray; Xiaoping Chen; Elizabeth J Rao; Mengxue Yang; Haihong Ye; Li Zhu; Jianghong Liu; Meng Xu; Yanlian Yang; Chen Wang; David Zhang; Eileen H Bigio; Marsel Mesulam; Yan Shen; Qi Xu; Kazuo Fushimi; Jane Y Wu
Journal:  Nat Struct Mol Biol       Date:  2011-06-12       Impact factor: 15.369

3.  Forebrain degeneration and ventricle enlargement caused by double knockout of Alzheimer's presenilin-1 and presenilin-2.

Authors:  Ruiben Feng; Huimin Wang; Jianlin Wang; David Shrom; Xuemei Zeng; Joe Z Tsien
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-17       Impact factor: 11.205

Review 4.  Presenilin 1 Regulates Membrane Homeostatic Pathways that are Dysregulated in Alzheimer's Disease.

Authors:  Carol A Deaton; Gail V W Johnson
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

Review 5.  The role of presenilin and its interacting proteins in the biogenesis of Alzheimer's beta amyloid.

Authors:  Giuseppe Verdile; Samuel E Gandy; Ralph N Martins
Journal:  Neurochem Res       Date:  2006-08-31       Impact factor: 3.996

6.  Interleukin-18 alters protein expressions of neurodegenerative diseases-linked proteins in human SH-SY5Y neuron-like cells.

Authors:  Elina M Sutinen; Minna A Korolainen; Jukka Häyrinen; Irina Alafuzoff; Steven Petratos; Antero Salminen; Hilkka Soininen; Tuula Pirttilä; Johanna O Ojala
Journal:  Front Cell Neurosci       Date:  2014-08-07       Impact factor: 5.505

Review 7.  The Role of Interleukin-18, Oxidative Stress and Metabolic Syndrome in Alzheimer's Disease.

Authors:  Johanna O Ojala; Elina M Sutinen
Journal:  J Clin Med       Date:  2017-05-21       Impact factor: 4.241

Review 8.  The Amyloid-β Pathway in Alzheimer's Disease.

Authors:  Harald Hampel; John Hardy; Kaj Blennow; Christopher Chen; George Perry; Seung Hyun Kim; Victor L Villemagne; Paul Aisen; Michele Vendruscolo; Takeshi Iwatsubo; Colin L Masters; Min Cho; Lars Lannfelt; Jeffrey L Cummings; Andrea Vergallo
Journal:  Mol Psychiatry       Date:  2021-08-30       Impact factor: 15.992

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.